Delivery Order SPE2DR25D2010-SPE2DR26F5ASW
Award Date 4/1/26
Potential Completion Date 4/22/26
Potential Value $8.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ibrance 125 mg capsule supply (21-count packages), with completion required by March 24, 2026. Place of performance is Conshohocken, PA. The order was priced firm fixed price and carried no set-aside. This delivery order is issued against Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for Ibrance 125 mg tablets (7-count). Place of performance is Conshohocken, PA. Ultimate completion date is April 20, 2026. The order is firm fixed price with no set-aside and represents a call against the parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which supplies pharmaceutical products and medical...
- The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for supply of Ibrance 125 mg tablets (7 count) under firm fixed pricing. Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 20, 2026. This delivery order was issued under the parent IDC held by Cencora, Inc. (Amerisourcebergen's parent entity) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999...
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for supply of Ibrance 100 mg tablets under firm fixed price terms with an ultimate completion date of March 23, 2026. Place of performance is Conshohocken, PA. The order was issued without set-aside. Amerisourcebergen Drug Corp operates as a division of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs. The company holds a $999,999,999...
- The Defense Logistics Agency issued a $8,561.41 delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for IBRANCE 75 MG tablets (7-count units), with an ultimate completion date of April 22, 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing under a no-set-aside procurement. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical running through December 2026, which serves as the parent vehicle for...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for Ibrance 100 mg capsule (21-count), with a ceiling value of $8,559.84. Place of performance is Conshohocken, PA. Ultimate completion date is March 26, 2026. The order was issued under firm fixed-price terms with no set-aside. This delivery order is called against AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency issued a $17,119.68 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for supply of Ibrance 100 mg tablets under a firm fixed-price contract with completion by April 30, 2026. Place of performance is Conshohocken, PA. The order was issued without set-aside on a competitive basis. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as a critical federal pharmaceutical distributor, particularly for military healthcare systems through...
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 10, 2026, and is priced as firm fixed price with no set-aside. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply...
- <p>The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for Ibrance 125 mg tablets (7-count package).</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, a global pharmaceutical supply vehicle. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of April 20, 2026.</p>
- The Defense Logistics Agency issued a $25,684.23 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Ibrance 75 mg tablets (7-count packaging), with a completion date of March 31, 2026. The order is issued under the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is...